Featured Insights and Perspectives from Darwin
The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
March 9, 2026
amazon
CVS
Google Cloud
Cigna
March 2, 2026
Darwin's Our Take: Big Pharma, home health and digital health companies notch big-ticket deals
Learn More
March 2, 2026
Novo Nordisk
Gilead Sciences
gsk
unitedhealth
Merck
February 23, 2026
Darwin's Our Take: Humana’s CenterWell acquires Florida-based primary care provider MaxHealth
Learn More
February 23, 2026
primary care
fda
value-based care
healthcare
February 16, 2026
Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes
Learn More
February 16, 2026
vaccine
cdc
healthcare
February 9, 2026
Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports
Learn More
February 9, 2026
Eli Lilly
Novo Nordisk
drug
AstraZeneca
February 2, 2026
Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations
Learn More
February 2, 2026
unitedhealth
gsk
abbvie
Eli Lilly
healthcare
January 25, 2026
Darwin's Our Take: Health insurance CEOs catch flak at House hearings on affordability, blame others for high costs
Learn More
January 25, 2026
ourtake
health
healthcare
January 18, 2026
Darwin's Our Take: Anthropic, OpenAI unveil new AI tools for health care enterprises
Learn More
January 18, 2026
ourtake
AI
healthcare
health
healthcare technology
January 11, 2026
Darwin's Our Take: OpenAI introduces ChatGPT Health to further integrate users' health information
Learn More
January 11, 2026
Eli Lilly
health
healthcare technology
AI
January 5, 2026
health
fda
Novo Nordisk
December 22, 2025
Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products
Learn More
December 22, 2025
drugmaker
drug
american medical association
January 14, 2026
Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations
Learn More
January 14, 2026
ourtake
retatrutide
Stay Aware. Stay Informed.
Want to stay ahead of health care trends?
Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
